Archivio

Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial

A reason to SMILE – we reached Last Patient Last Visit

ODYSSEY trial data published in Lancet – shows increase in treatment options for older children living with HIV

Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial